Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 6, Issue 1
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Review Article
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
Online download statistics by month:
Online download statistics by month: December 2019 to February 2024
Abstract
Full
Pdf
Dec 2019
2
2
0
Jan 2020
20
20
1
Feb 2020
44
44
6
Mar 2020
58
58
9
Apr 2020
94
94
13
May 2020
72
72
5
Jun 2020
51
51
23
Jul 2020
39
39
15
Aug 2020
31
31
12
Sep 2020
62
62
7
Oct 2020
86
86
19
Nov 2020
92
93
18
Dec 2020
100
100
18
Jan 2021
98
98
24
Feb 2021
112
113
22
Mar 2021
157
157
44
Apr 2021
110
110
38
May 2021
115
115
36
Jun 2021
105
105
20
Jul 2021
71
71
20
Aug 2021
46
46
10
Sep 2021
75
75
24
Oct 2021
121
121
51
Nov 2021
107
106
34
Dec 2021
102
102
25
Jan 2022
141
149
28
Feb 2022
98
100
28
Mar 2022
143
153
26
Apr 2022
124
128
31
May 2022
171
173
38
Jun 2022
129
140
37
Jul 2022
100
104
27
Aug 2022
137
137
28
Sep 2022
142
145
21
Oct 2022
108
110
20
Nov 2022
121
125
32
Dec 2022
101
102
13
Jan 2023
140
141
23
Feb 2023
92
92
20
Mar 2023
141
143
31
Apr 2023
377
379
116
May 2023
98
100
29
Jun 2023
85
85
9
Jul 2023
90
91
18
Aug 2023
135
136
26
Sep 2023
88
89
22
Oct 2023
103
105
15
Nov 2023
132
135
20
Dec 2023
87
87
14
Jan 2024
60
62
13
Feb 2024
80
81
18
Total
5193
5263
1197
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?